IntroductionrnStroke is an important disease that is prevalent worldwide [1-3].Ischemic stroke accounts for 80％ of stroke cases.Currently,evidence-based effective treatments for ischemic stroke are limited,and only intravenous thrombolysis with Alteplase (a commercially available thrombolytic agent) within 4.5 h of stroke onset and thrombectomy and arterial thrombolysis within 6-24 h of onset are effective [4,5].However,because these two treatments have strict indications and certain risks (reperfusion injury and bleeding) [5-8],there is an urgent need to develop new treatment methods.Thus,comprehensive elucidation of the molecular mechanisms underlying ischemic brain damage and the search for key signaling pathways and protein molecules are important for guiding the clinical treatment of ischemic stroke.